Alexion unveils positive top-line results from phase 3 study of Ultomiris in aHUS

Image: Alexion announced phase 3 study of ULTOMIRIS has achieved primary objective in complement inhibitor-naïve patients with aHUS. Photo: courtesy of krishna arts / FreeDigitalPhotos.net.